ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Sold by OLD Mission Capital LLC
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Sold by OLD Mission Capital LLC
OLD Mission Capital LLC lessened its holdings in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) by 52.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,311 shares of the company's stock after selling 16,895 shares during the period. OLD Mission Capital LLC owned approximately 3.83% of ProShares UltraShort Nasdaq Biotechnology worth $413,000 as of its most recent SEC filing.
根據舊任務資本有限責任公司向美國證券交易委員會(納斯達克)披露的最新信息，其在第二季度減持了ProShares UltraShort美國證券交易委員會生物科技公司(BIS-GET評級)的股票52.5%。該公司在此期間出售了16,895股後，持有15,311股該公司股票。根據納斯達克最近提交的申請文件，舊任務資本有限責任公司擁有ProShares UltraShort美國證券交易委員會生物科技公司約3.83%的股份，價值413,000美元。
Separately, UBS Group AG grew its holdings in ProShares UltraShort Nasdaq Biotechnology by 54.7% during the first quarter. UBS Group AG now owns 1,371 shares of the company's stock worth $33,000 after acquiring an additional 485 shares during the period.
另外，瑞銀集團(UBS Group AG)第一季度增持了ProShares UltraShort納斯達克生物科技公司的股份54.7%。瑞銀集團(UBS Group AG)在此期間增持了485股，目前持有1,371股該公司股票，價值33,000美元。
ProShares UltraShort Nasdaq Biotechnology Stock Up 2.7 %
ProShares UltraShort納斯達克生物科技股上漲2.7%
Shares of BIS stock opened at $21.03 on Thursday. The business's fifty day moving average price is $23.46 and its 200 day moving average price is $25.46. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $18.77 and a 1-year high of $35.64.
週四，國際清算銀行股票開盤報21.03美元。該業務的50日移動均線價格為23.46美元，200日移動均線價格為25.46美元。ProShares UltraShort納斯達克生物科技的一年低點為18.77美元，一年高位為35.64美元。
ProShares UltraShort Nasdaq Biotechnology Profile
ProShares UltraShort納斯達克生物技術簡介
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
ProShares超納斯達克生物科技(基金)只尋求一天的投資結果，不尋求較長時期的投資結果。基金尋求扣除費用和費用前的每日投資結果，相當於該指數每日業績的兩倍(200%)。超過一個交易日的基金回報將是這段時間內每一天的回報的複合結果，這很可能與同期納斯達克生物技術指數(該指數)的回報兩倍(200%)不同。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- Is Triple-Digit Growth Ahead For Digital Ad Platform Trade Desk?
- EV Maker Lucid Falls On Declining Orders, Rivian Up On Guidance
- DoorDash Outperforms Despite Losses – Is It Time To Buy?
- Goodyear Tire & Rubber Stock is Becoming a Mighty Good Bargain
- Analysts Rate DraftKings a Moderate Buy As Growth Slows
- 免費獲取StockNews.com關於ProShares UltraShort納斯達克生物技術的研究報告
- 數字廣告平臺交易臺未來是否會實現三位數的增長？
- 電動汽車製造商Lucid訂單下降，Rivian發佈指引
- DoorDash在虧損的情況下表現優異-是時候買入了嗎？
- 固特異輪胎橡膠庫存正在成為一筆劃算的交易
- 分析師對DraftKings的評級為温和買入，經濟增長放緩
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
獲得ProShares UltraShort納斯達克生物科技日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對ProShares UltraShort納斯達克生物技術和相關公司的最新新聞和分析師評級的每日摘要。
譯文內容由第三人軟體翻譯。